[Value of immunobiological tests in Menière's disease and in rapidly progressive sensorineural deafness]

J M Lejeune1, R Charachon

  • 1C.H.R.U. Grenoble, Clinique O.R.L., Grenoble, France.

Insights

Immunobiologic tests identified inflammation in Meniere's disease and sensorineural hearing loss. Specific inner ear antibodies correlated with better hearing improvement after corticosteroid therapy.

Area of Science:

  • Immunology
  • Otolaryngology
  • Audiology

Context:

  • Meniere's disease and rapidly progressive sensorineural hearing loss can have autoimmune components.
  • Investigating immunobiologic markers aids in understanding disease mechanisms.

Purpose:

  • To identify abnormal immunobiologic tests in Meniere's disease and rapidly progressive sensorineural hearing loss.
  • To assess the correlation between immunologic findings and treatment response.

Summary:

  • 12 Meniere's disease and 11 rapidly progressive sensorineural hearing loss cases were tested for non-specific inflammatory markers and inner ear specific antibodies.
  • Over 50% showed non-specific inflammation; 30% had positive specific inner ear tests.
  • Corticosteroid therapy improved hearing in 100% of patients with positive specific tests versus 50% with negative tests.

Impact:

  • Suggests a potential role for immunologic testing in diagnosing and guiding treatment for these hearing disorders.
  • Highlights the efficacy of corticosteroids in patients with confirmed autoimmune inner ear disease.

Related Concept Videos